EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Toxicity profile of breast cancer chemotherapies in the department of gynecology-obstetrics and reproductive medicine of the Souro Sanou University Hospital Center

Maneguedo Alexandre BOENA, Mohamed Dieudonné Ouattara, Stephanie Mariama Millogo, Tindaogo Serge Soumdaogo

Revue Africaine des Sciences Sociales et de la Sante Publique · 2026 · 8 (2) · 193-200

DOI: 10.4314/rasp.v8i2.13 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revue Africaine des Sciences Sociales et de la Sante Publique, 2026. Verfasst von Maneguedo Alexandre BOENA und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In more than 60% of cases in our setting, cancer is diagnosed at an advanced stage. At these stages, cytotoxic chemotherapy is the most commonly used treatment. These drugs have side effects that can impair patients’ quality of life and compromise their chances of recovery. The objective is to report on the various toxicities of chemotherapy for breast cancer in order to plan for their effective management. This was a descriptive cross-sectional study conducted over a six-month period that included all female patients receiving chemotherapy for breast cancer. The variables included sociodemographic factors, cancer-related factors, the patient’s WHO performance status, the chemotherapy regimen, immediate and late toxicities within the first six months, and clinical outcomes. We included 92 female patients with a mean age of 37 years (range, 19-71 years). The incidence of toxicity was 91.35% across all grades. The most common toxicities were gastrointestinal: nausea and vomiting (91.3%), diarrhoea (37%), mucositis (27.2%), and constipation (15.2%); hematologic toxicity: anaemia (68.5%), neutropenia (46.7%), and thrombocytopenia (18.5%); and alopecia (70.7%). The median time to onset was less than 10 days. Outpatient management was provided in 75% of cases. The outcome was favorable in 81% of cases. Toxicities during chemotherapy are very common. Prevention and patient education remain the best strategies for managing them.

Zitieren

APA

BOENA, M. A., Ouattara, M. D., Millogo, S. M., & Soumdaogo, T. S. (2026). Toxicity profile of breast cancer chemotherapies in the department of gynecology-obstetrics and reproductive medicine of the Souro Sanou University Hospital Center. Revue Africaine des Sciences Sociales et de la Sante Publique, 8(2), 193-200. https://doi.org/10.4314/rasp.v8i2.13

Vancouver

BOENA MA, Ouattara MD, Millogo SM, Soumdaogo TS. Toxicity profile of breast cancer chemotherapies in the department of gynecology-obstetrics and reproductive medicine of the Souro Sanou University Hospital Center. Revue Africaine des Sciences Sociales et de la Sante Publique. 2026;8(2):193-200. doi:10.4314/rasp.v8i2.13

BibTeX
@article{BOENA2026,
  author = {BOENA, Maneguedo Alexandre and Ouattara, Mohamed Dieudonné and Millogo, Stephanie Mariama and Soumdaogo, Tindaogo Serge},
  title = {Toxicity profile of breast cancer chemotherapies in the department of gynecology-obstetrics and reproductive medicine of the Souro Sanou University Hospital Center},
  journal = {Revue Africaine des Sciences Sociales et de la Sante Publique},
  year = {2026},
  volume = {8},
  number = {2},
  pages = {193--200},
  doi = {10.4314/rasp.v8i2.13}
}
Kostenlos starten →